OR WAIT 15 SECS
Pharmaceutical Executive
March 19, 2008
News Analysis
0
The US pharma market grew just 3.8 percent last year, according to IMS Health. The big loser: lipid regulators. The winners: Biologic response modulators and monoclonal antibodies.